Ciprofloxacin Oral, Injection products

Exceptions or additions to the recognized standards

	Minimum Inhibitory Concentrations (mcg/mL)			Disk Diffusion (zone diameter in mm)
Pathogen	S	I	R	S	I	R
Streptococcus pneumoniae	≤1	2	≥4	≥21	16-20	≤15
Streptococcus spp. β- Hemolytic Group	≤1	2	≥4	≥21	16-20	≤15

S = Susceptible; I = Intermediate; R = Resistant

For these bacteria listed below, susceptibility test interpretive criteria are not recognized at this time:

Acinetobacter spp.

Other Non-Enterobacterales

Neisseria meningitidis